ArticleEmerging microbes & infectionsPublished
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
13 of 39 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Counties
- Mercer County, Philadelphia County
Publication record
- Type
- Article
- Venue
- Emerging microbes & infections
- Published
- Topic
- Disease research
- Subject terms
- CD4-Positive T-Lymphocytes; Humans; HIV-1; HIV Infections; Immunoglobulin G; Vaccines, DNA; AIDS Vaccines; HIV Antibodies; Immunization, Secondary; Adolescent; Adult; Middle Aged
- PubMed ID
- 40190112
- PubMed Central ID
- PMC11980190
- Open access
- Yes, open
- Added to directory
- Source checked